AMMAN — The
pharmaceutical industries and
medical supplies sector in Jordan have witnessed significant growth in exports, with an increase
of 29.7 percent during the first five months of this year compared to the
corresponding period last year.
اضافة اعلان
Export figures provided by Fadi Al-Atrash, the sector's
representative at the Jordan Chamber of Industry, reveal that exports reached
approximately JD266 million in the initial five months of this year, marking a
noteworthy rise from JD205 million in the same period last year.
Exports enter 85 global marketsAccording to the Jordan News Agency, Petra, Atrash declared
that the sector's exports have successfully reached 85 global markets.
The growth in the pharmaceutical industry has been registered
across the three chambers of industry in the Kingdom, with Zarqa witnessing a
63.7 percent increase, Amman 28.5 percent, and the Irbid Chamber of Industry
observing a 9.8 percent growth.
Regularized supply chains and recovery drive growthAtrash attributed this growth to the regularization and
recovery of supply chains, which has ensured an uninterrupted supply of raw
materials, packaging, and production inputs.
The production chain has also played a vital role in
boosting production and sales, Atrash said.
Atrash also acknowledged the resilience of companies that
have bounced back from the adverse impact of the COVID-19 pandemic, targeting
growth and expansion into new and non-traditional markets.
European market access and export resumption to Algeria
The sector representative highlighted that some firms have
secured European Good Manufacturing Practice Certificates, enabling them to
export to the lucrative European market.
Additionally, he noted the resumption of export activities
to Algeria, which stands as one of the largest pharmaceutical markets in the
region.
Atrash applauded the unwavering support of the Jordan Food
and Drug Administration in expediting the registration of local products, which
has subsequently led to the expansion of exports.
He emphasized the uniqueness and diversity of modern and
innovative pharmaceutical forms, as well as the advancement of production
lines, reflecting the significant development of the Jordanian medicine and
medical supplies industry.
Regional hub for pharmaceutical manufacturing
Furthermore, Atrash stressed the importance of a robust
public-private partnership in empowering the sector to become a regional hub
for pharmaceutical manufacturing.
Such cooperation also facilitates investment in research and
development, leading to the production of new therapeutic groups that
positively influence the growth of Jordanian exports.
Jordan's pharmaceutical sector at a glance
The pharmaceutical and medical supplies sector in Jordan
comprises 151 facilities with a registered capital of about JD341 million.
Additionally, there are 15 Jordanian factories operating outside the Kingdom,
specifically in Saudi Arabia, Algeria, Egypt, Morocco, and Sudan.
Reflecting on the vision of economic modernization, Atrash
underscored its pivotal role in supporting the sector as a vital and steadily
growing industry. The vision aims to enhance exports to reach 2.1 billion
dinars, create employment for 16,000 individuals, and increase the contribution
to the GDP to JD1.7 billion by 2033.
Atrash, who also serves as CEO and Board Member of the Amman
Pharmaceutical Industries, mentions the vision's ambition to attract
investments worth JD1.1 billion over the next decade.
This influx of investment will aid in transforming the
sector into a regional center for pharmaceutical products through technological
adoption, development of new drugs, market expansion, and achieving
pharmaceutical security for Jordan and the surrounding region.
Read more National news
Jordan News
.jpg)
.jpg)
